Abnormal uterine bleeding
Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more
The National External Quality Assessment Service (NEQAS) has recently introduced an external quality assessment programme for CoaguChek XS and CoaguChek XS Plus. The CoaguChek meters remain one of the only group of meters of its kind to have undergone a full independent assessment, that gives users complete confidence in the accuracy and precision of the results.
The availability of an external quality assessment scheme is expected in most near-patient testing protocols. CoaguChek XS and XS Plus have an ISI of 1.0
CoaguChek XS and XS Plus have a batch to batch coefficient variation (CV) of 4.5%
Overall this means that healthcare professionals can be reassured that CoaguChek XS and CoaguChek XS Plus meters are accurate and precise, giving the user complete confidence.
Patient research Results:
Recent patient research demonstrated that despite the proven safety and effectiveness and the positive impact on patient quality of life, the number of patients being encouraged to manage their own warfarin testing is low. However, those that did participate in self-testing reported great personal and clinical benefits.
Those patients already self-testing described total confidence in the reliability and accuracy of results and experienced increased independence, control, convenience, time saving and improved quality of life.
Healthcare professionals, with support from Roche Diagnostics and patient groups such as AntiCoagulation Europe, should feel confident to discuss the benefits of patient self-testing with their patients.
"In practical terms, self-testing quite simply changed my life. I was able to be much more independent and no longer had to arrange everything around appointments. Travelling was not a problem - I could just phone or email from wherever I happened to be. In addition, I was able to test whenever I had a particular reason to suspect I might be unstable. To me, this made perfect sense and gave me peace of mind that everything was OK." John Chisholm, Patient
Roche Diagnostics - 30 Years at the Top of Point of Care
Quick search - use * for an abbreviated search, eg nico*
Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more
Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more
Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more
As many as 10% of patients admitted to hospital suffer some form of harm, much of which is avoidable... Read more
Closer working between GPs and community pharmacists could help to save lives and may prove to be mo... Read more
Dispensing practices in Fife are battling an application to open a new pharmacy, weeks after defeati... Read more
The GPC must negotiate 'new contractual incentives' to encourage practices to take on partners, the ... Read more
Doctors who want to go on working in the UK after November must tell the GMC by 14 August. Read more
Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more
Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more
Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more
Comments
Only registered users may comment. Log in now or register for a free account.
There are problems with your form submission.
Please review the errors shown below.